Viewing Study NCT05722795


Ignite Creation Date: 2025-12-24 @ 1:33 PM
Ignite Modification Date: 2025-12-30 @ 8:08 PM
Study NCT ID: NCT05722795
Status: RECRUITING
Last Update Posted: 2025-07-09
First Post: 2022-04-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Use of Imatinib to Convert Triple Negative Breast Cancer Into ER-positive Breast Cancer (I-CONIC)
Sponsor: Vastra Gotaland Region
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module